does glp 1 cause hypoglycemia Hypoglycaemia from GLP-1 Injections Hypoglycemia following the use of

Experts Urge Caution Not all experts agree that the findings should influence medical conclusions

NICE guidance on diabetes management does not endorse GLP-1 receptor agonists for breastfeeding women

Very common (10% of patients) Nausea peaks during titration, typically subsides within 48 weeks at a stable dose Vomiting, diarrhoea, constipation Abdominal pain or discomfort Reduced appetite (this is the therapeutic effect, not an adverse effect) Less common but serious stop and see a doctor Severe, persistent abdominal pain radiating to the back possible pancreatitis Right upper abdomen pain, fever, yellowing possible gallstones / gallbladder disease Persistent neck lump, hoarseness, difficulty swallowing evaluate thyroid Rapid heartbeat, severe dehydration from vomiting Hypoglycaemia when semaglutide is combined with insulin or sulfonylureas What the Indian data shows: a 2025 study of Indian patients found GI side effects are the leading cause of discontinuation, peaking during dose escalation

To enhance patient outcomes, a multifaceted approach is recommended, encompassing regular weekly follow-ups to improve adherence, nutritional support emphasizing protein-rich and fiber-heavy diets, cost assistance to facilitate access to insurance-covered options, and the integration of digital health tools such as apps for reminders and progress tracking

Comprehensive patient support should be provided throughout the weight loss journey, encompassing pre-treatment preparation, continuous assistance during both the active weight loss and maintenance phases, as well as guidance in the event of potential therapy discontinuation